Press Releases

Board Continues to Unanimously Recommend Shareholders Vote "FOR" All ProposalsNEW YORK, June 12, 2026 /PRNewswire/ -- Net Lease Office Properties Inc. ("NLOP" or the "Company") announced that its 2026 Annual Meeting of Shareholders (the "Annual Meeting"), held on June 12, 2026 at 10:00 a.m. Eastern Time, was convened and adjourned without any business being conducted, in order to provide additional time for the Company to solicit proxies. NLOP's Board of Trustees unanimously recommends that shareholders vote "FOR" all proposals.The Annual Meeting will reconvene virtually on June 25, 2026 at 9:30 a.m. Eastern Time to provide sha

Savara Inc. (NASDAQ:SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to new employees. On June 11, 2026, the Compensation Committee of Savara's Board of Directors granted the inducement awards to four new employees who recently joined the Company. The inducement awards consist of options to purchase 36,500 shares of the Company's common stock, restricted stock units (RSUs) covering 42,500 shares of the Company's common stock, and performance stock units (PSUs) covering 8,000 shares of the Company's common stock. These equity awards were granted under the Savara Inc. 2021 Inducement Equity Incentive Plan

EMERYVILLE, Calif., June 12, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ:XOMA) ("XOMA" or the "Company") today announced that its Board of Directors has authorized the following cash dividends to holders of XOMA Royalty's (i) 8.625% Series A Cumulative Perpetual Preferred Stock (NASDAQ:XOMAP) (the "Series A Preferred Stock") (984,000 shares outstanding, CUSIP No. 98419J305) and (ii) depositary shares representing its 8.375% Series B Cumulative Perpetual Preferred Stock (NASDAQ:XOMAO) (represented by 1,760,500 Depositary Shares) (the "Series B Preferred Stock", and together with the Series A Preferred Stock, the "Preferred Stock") (CUSIP No. 98419J404). In addition, on July 14

EMERYVILLE, Calif., June 12, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (NASDAQ:FDMT, 4DMT or the Company)), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that on June 9, 2026, the compensation committee of the Company's board of directors granted seven new non-executive employees 66,900 Restricted Stock Units (RSUs). The RSUs were granted pursuant to the Company's 2025 Employment Inducement Award Plan, as amended, under Rule 5635(c)(4) of The Nasdaq Global Market for equity grants to induce new employees to enter into empl

SPOKANE, Wash., June 12, 2026 (GLOBE NEWSWIRE) -- Avista announced today it is taking additional time to evaluate the processing of energy requests from new large data center developers as it seeks to partner with governmental agencies on creating a clear and coordinated planning process and as the company considers additional stakeholder feedback. Negotiations concerning energy service to this potential data center are now paused. The decision follows recent community interest and concern related to Avista's previously announced Memorandum of Understanding (MOU) with the new 500MW data center developer. "We've heard the questions and concerns from our customers, community members and lo

Shakopee, Minn., June 12, 2026 (GLOBE NEWSWIRE) -- Canterbury Park Holding Corporation ("Canterbury" or the "Company") (NASDAQ:CPHC), today announced that the Company's Board of Directors, pursuant to its dividend policy, approved a quarterly cash dividend of $0.07 per share that will be paid on July 14, 2026 to stockholders of record on June 30, 2026. At this quarterly rate, the annual dividend is equivalent to $0.28 per common share. About Canterbury Park Canterbury Park Holding Corporation (NASDAQ:CPHC) owns and operates Canterbury Park Racetrack and Casino in Shakopee, Minnesota, the only thoroughbred and quarter horse racing facility in the State. The Company generally offers live r

FREDERICK, Md., June 12, 2026 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ:RNAC) (the "Company"), a late clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the granting of an inducement award to one new employee. On June 8, 2026, the Company issued to this employee an option to purchase an aggregate of 6,100 shares of the Company's common stock with an exercise price of $5.86, the closing trading price of the Company's common stock on the Nasdaq Global Market on the date of grant. The option was granted pursuant to the Company's Amended and Restated 2018 Employment Inducement Incentive Award Plan and was approved by the Company

SCHAFFHAUSEN, Switzerland, June 12, 2026 (GLOBE NEWSWIRE) -- Monolithic Power Systems, Inc. ("MPS") (NASDAQ:MPWR), a global company that provides high-performance, semiconductor-based power electronics solutions, announced today its second quarter dividend of $2.00 per common share to all stockholders of record as of the close of business on June 30, 2026. The dividend will be paid on July 15, 2026. Safe Harbor Statement This news release includes "forward-looking statements" intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on our current expectations, estimates and projec

BOSTON, June 12, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it will host a live conference call and webcast on Saturday, June 13 at 9:00 a.m. ET/8:00 a.m. CT to discuss interim six-month results from the Company's Phase 2 trial evaluating setmelanotide in patients with Prader-Willi syndrome (PWS). David Meeker, M.D., Chairman, President and Chief Executive Officer will be joined by Jennifer Miller, M.D., Pediatric Endocrinology, University of Florida College of Medicine to discuss the data. Conference Ca

Repaid in full the existing EIB Loans1 in an amount of approximately €62 million and completed repurchase of all 2,266,023 existing EIB Tranche A Warrants and 700,000 of existing EIB Tranche B Warrants2 (corresponding to approximately 22.7 million Underlying Shares) for a repurchase price of €50 million Issued the Tranche A Convertible Bonds (€35 million) and the Tranche B Amortized Bonds (€40 million), for an initial aggregate drawdown of €75 million under the Debt Financing Transaction3 with funds and accounts managed by BlackRock and Claret Capital Partners Daix (France), New York City (New York, United States), June 12, 2026 – Inventiva (Euronext Paris and NASDAQ:IVA) ("Inventiva" or th

Atara Biotherapeutics, Inc. (NASDAQ:ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced the departure of Carol Gallagher, Pharm D from its Board of Directors. "On behalf of Atara and its Board of Directors, I want to express my gratitude to Carol for her dedication to our company and its shareholders over the past thirteen years," said Cokey Nguyen, President and Chief Executive Officer of Atara. "Carol has been a pillar on the Board of Directors serving in multiple roles over the course of her tenure. We wish Carol continued s

SPRINGFIELD, N.J., June 12, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Village Super Market, Inc. (NSD:VLGEA) declared quarterly cash dividends of $0.25 per Class A common share and $0.1625 per Class B common share. The dividends will be payable on July 23, 2026 to shareholders of record at the close of business on July 2, 2026. Village Super Market operates a chain of 34 supermarkets in New Jersey, New York, Maryland and Pennsylvania under the ShopRite and Fairway banners and three Gourmet Garage specialty markets in New York City. Contact:John Van Orden, CFO (973) 467-2200 VillageInvestorRelations@wakefern.com  

CHICAGO, June 12, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its wholly-owned subsidiary, Cana Laboratories ("Cana"), has received new contract manufacturing orders from Nassington and Verisfield for a combined 253,657 units across a range of medicines and other pharmaceutical products. Under the orders, Cana will manufacture Gritse oral solution 0.4 mg/ml (bottle x 150 ml); Gritse forte oral solution 2 mg/ml (bottle x 50 ml); Gritse forte oral solution 4 mg/ml (bottle x 50 ml); Fungofort cutaneous spray, solution (30 ml); Paco-4 tablets (250+250+65+35 mg);

ARCHBOLD, Ohio, June 12, 2026 (GLOBE NEWSWIRE) -- F&M Bank ("F&M"), an Archbold, Ohio-based bank owned by Farmers & Merchants Bancorp, Inc. (NASDAQ:FMAO), is bringing back one of summer's most anticipated community adventures: The Great Briefcase Hunt. Beginning June 15, the community across the F&M footprint will once again have the chance to follow weekly clues in search of a hidden briefcase worth $10,000 – with $5,000 awarded to the winner and $5,000 donated to a local charity from an approved F&M charity list. After generating excitement across communities in 2025, The Great Briefcase Hunt returns bigger, bolder, and ready to spark another summer of mystery, teamwork, and adventure.

Qnity Electronics, Inc. ("Qnity") (NYSE:Q), a premier technology solutions leader across the semiconductor value chain, today announced that Jon Kemp, Qnity's Chief Executive Officer, will participate in a fireside chat at the Wolfe Research 3rd Annual Materials of the Future Conference on June 16, 2026, at 8:35 a.m. ET. A live webcast of the fireside chat will be available at Events | Qnity Electronics, Inc. (Q). A replay of the webcast will be available following the conclusion of the event. About Qnity Qnity is a premier technology provider across the semiconductor value chain, empowering AI, high performance computing, and advanced connectivity. From groundbreaking solutions for sem

Wuxi, China, June 12, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd., (NASDAQ:BYAH) an exempted company with limited liability incorporated under the laws of the Cayman Islands (the "Company"), today announced that it has entered into a securities purchase agreement with several investors for the sales of the Company's securities in a registered direct offering (the "Offering") consisting of up to 1,133,332 of the Company's Class A ordinary shares, par value $0.001 each (the "Shares"), and pre-funded warrants (the "Pre-Funded Warrants") to purchase up to 200,000 Class A ordinary shares (the "Warrant Shares"), at a combined purchase price of $1.50 per Share and Pre-Funded

Post-combination company, SL Science Holding Limited, to commence trading on the Nasdaq Stock Market under the ticker symbol "SLBT"Transaction provides strategic capital to advance proprietary Gamma delta T cell-based "off-the-shelf" cellular therapies for solid tumor indications, including pancreatic and brain cancersLeadership team bolstered by seasoned executives and highly experienced independent directors to drive the next phase of clinical and commercial growth TAIPEI, Taiwan, June 12, 2026 (GLOBE NEWSWIRE) -- SL BIO Ltd. ("SL Bio" or the "Company"), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies, today announced the closi

The New York Times Company's Board of Directors today declared a regular quarterly dividend of $0.23 per share on the Company's Class A and Class B common stock. The dividend is payable on July 23, 2026, to shareholders of record as of the close of business on July 8, 2026. The New York Times Company (NYSE:NYT) is a trusted source of quality, independent journalism whose mission is to seek the truth and help people understand the world. With more than 13 million subscribers across a diverse array of print and digital products — including news, games, sports, cooking and shopping advice — The Times has evolved from a local and regional news leader into a diversified media company with curi

ABBOTT PARK, Ill., June 12, 2026 /PRNewswire/ -- The board of directors of Abbott (NYSE:ABT) today declared a quarterly common dividend of 63 cents per share. This marks the 410th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Aug. 17, 2026, to shareholders of record at the close of business on July 15, 2026.Abbott has increased its dividend payout for 54 consecutive years and is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies that have increased dividends annually for at least 25 consecutive years.About Abbott:Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of

Aggressive Output. Rugged Reliability. The new series is purpose-built for SPL competition vehicles and performance-focused builds where maximum output matters most.TEMPE, Ariz., June 12, 2026 /PRNewswire/ -- Rockford Fosgate, the leader in high-performance audio systems, is proud to announce the new PUNCH PRO Speaker Series, engineered to be the loudest speakers in the PUNCH lineup. Purpose-built for SPL competition vehicles, high-volume street performance, and performance-focused builds, the new PUNCH PRO Series delivers aggressive output, rugged reliability, and the unmistakable PUNCH sound. Designed for listeners who demand